CIK 0000949858
- Non-accelerated filer
- Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 954343413
- Phone
- +1 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
- 4 Open-market sale EVP, CMO sold 3,254 shares at $0.83 ($2,701)
- 4 Open-market sale CFO sold 834 shares at $0.83 ($692)
- 4 Open-market sale President and CEO sold 12,033 shares at $0.83 ($9,987)
- 4 Exercise or conversion Director acquired 5,359 shares (option exercise)
- 4 Open-market sale CFO sold 1,427 shares at $2.76 ($3,939)
- 4 Open-market sale EVP, CMO sold 1,408 shares at $2.69 ($3,788)
- 4 Open-market sale President and CEO sold 4,571 shares at $2.69 ($12,296)
- 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 5,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 2,500 shares (option exercise)
- 4 Open-market sale EVP, CMO sold 2,092 shares at $1.88 ($3,933)
- 4 Open-market sale President and CEO sold 7,543 shares at $1.88 ($14,181)
Page 13 of 24 · 465 filings